Irvine, Calif.-based Cell Vitals may have to rein in its claims for ReLuma skin-care products, touted as containing cell-signaling protein molecules derived from adult stem cells, following FDA’s Nov. 24 warning letter to the firm.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?